Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.94 CHF | +0.52% |
|
+2.36% | +21.73% |
06-07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
05-22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SANDOZ GROUP AG | Generic Pharmaceuticals | +0.52% | +2.36% | +21.73% | - | - | 15.93B | ![]() | ![]() | ![]() |
Technical Rankings Surperformance
- Stock Market
- Equities
- SDZ Stock
- Charts Sandoz Group AG
- Comparison Chart